The STAT3 oncogene as a predictive marker of drug resistance
- 1 January 2007
- journal article
- opinion
- Published by Elsevier BV in Trends in Molecular Medicine
- Vol. 13 (1), 4-11
- https://doi.org/10.1016/j.molmed.2006.11.001
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Stat3 Is Required for Full Neoplastic Transformation by the Simian Virus 40 Large Tumor AntigenMolecular Biology of the Cell, 2005
- Implications of an antiparallel dimeric structure of nonphosphorylated STAT1 for the activation–inactivation cycleProceedings of the National Academy of Sciences, 2005
- Structural Bases of Unphosphorylated STAT1 Association and Receptor BindingMolecular Cell, 2005
- Implication of BRG1 and cdk9 in the STAT3-mediated activation of the p21waf1 geneOncogene, 2004
- The STATs of cancer — new molecular targets come of ageNature Reviews Cancer, 2004
- What does Stat3 do?JCI Insight, 2002
- Stat proteins and oncogenesisJCI Insight, 2002
- Functional Interaction of STAT3 Transcription Factor with the Coactivator NcoA/SRC1aJournal of Biological Chemistry, 2002
- Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3Genes & Development, 1999
- Synergistic Signaling in Fetal Brain by STAT3-Smad1 Complex Bridged by p300Science, 1999